A Rollover Study of CC-122
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Non-Hodgkin Lymphoma
Related studies linked through entity extraction aliases.
WTX-330 in Patients With Advanced or Metastatic Solid Tumors or Non-Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Siltuximab for the Prevention of CAR T Cell Related Cytokine Release Syndrome in Patients With CD19 Positive Non-Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
NKTR-255 vs Placebo Following CD19-directed CAR-T Therapy in Patients With Relapsed/Refractory Large B-cell Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3
A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma
- Status
- RECRUITING
- Phase
- PHASE3
A Safety and Efficacy Study Evaluating CTX112 in Subjects With Relapsed or Refractory B-Cell Malignancies
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of GNC-038 Injection in Patients With Relapsed or Refractory NK/ T-cell Lymphoma, AITL, and Other NHL
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
First in Human, Dose Escalation, Dose Expansion Study of AUR105
- Status
- TERMINATED
- Phase
- PHASE1
AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma
- Status
- RECRUITING
- Phase
- PHASE1
Methotrexate, Tafasitamab, Lenalidomide and Rituximab in Patients With PCNSL
- Status
- RECRUITING
- Phase
- PHASE2
A Study of Radiation Therapy Before CAR T Cell Therapy for People With B Cell Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
The Effect of Decision Support System on Symptom Self-Management in Non-Hodgkin Lymphoma Patients
- Status
- COMPLETED
- Phase
- NA
Pomalidomide and Dose-Adjusted EPOCH +/- Rituximab for HIV-Associated Lymphomas
- Status
- RECRUITING
- Phase
- PHASE1
Study of VIP152, Venetoclax, and Prednisone (VVIP) in Relapsed/Refractory Lymphoid Malignancies
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Isatuximab During Stem Cell Collection and Transplant in Patients With Multiple Myeloma and Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Long-Term Follow-up Study
- Status
- ENROLLING_BY_INVITATION
- Phase
- N/A
Study of 3D189 in Patients With Hematologic Malignancies
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Evaluation of Safety and Efficacy of Allo GDA-201 Natural Killer (NK) Cells in Patients With Relapsed/Refractory B Cell NHL
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Treatment of Chinese Participants With B-Cell Malignancies With BGB-16673, a Bruton Tyrosine Kinase-Targeted Protein-Degrader
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study to Evaluate Adverse Events and Change in Disease Activity of Subcutaneous (SC) Epcoritamab in Combination With Oral and Intravenous Anti-Neoplastic Agents in Adult Participants With Non-Hodgkin Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2